ProQR Therapeutics N.V. (PRQR) Executive Compensation
ProQR Therapeutics N.V. (PRQR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PRQR
CIK: 1612940
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: P7
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG Accountants N.V.
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerBastiaan Geerling
Audit LocationAmstelveen, Netherlands
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-09-23 | 2026-09-23 | FORM 6-K | 0001104659-26-109819 | View SEC Doc Filr Page |
| 6-K | 2026-09-09 | 2026-09-09 | FORM 6-K | 0001104659-26-106138 | View SEC Doc Filr Page |
| 6-K | 2026-08-13 | 2026-06-30 | 6-K | 0001104659-26-095425 | View SEC Doc Filr Page |
| 6-K | 2026-08-13 | 2026-08-13 | FORM 6-K | 0001104659-26-095422 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-31 | OWNERSHIP DOCUMENT | 0001104659-26-089780 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-29 | — | SCHEDULE 13D/A Filing | 0001104659-26-088126 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0001716774-26-000021 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-24 | — | SCHEDULE 13G/A Filing | 0000059478-26-000071 | View SEC Doc Filr Page |
| 4 | 2026-07-21 | 2026-07-17 | OWNERSHIP DOCUMENT | 0001104659-26-085234 | View SEC Doc Filr Page |
| EFFECT | 2026-07-15 | — | EFFECT Filing | 9999999995-26-002315 | View SEC Doc Filr Page |
| 424B5 | 2026-07-15 | — | 424B5 | 0001104659-26-083906 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-15 | — | SCHEDULE 13G/A Filing | 0001104659-26-083818 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-07-09 | OWNERSHIP DOCUMENT | 0001104659-26-082890 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-07 | OWNERSHIP DOCUMENT | 0001104659-26-081762 | View SEC Doc Filr Page |
| F-3 | 2026-07-06 | — | F-3 | 0001104659-26-080750 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-30 | — | SCHEDULE 13D/A Filing | 0001104659-26-079415 | View SEC Doc Filr Page |
| 4/A | 2026-06-30 | 2026-06-02 | OWNERSHIP DOCUMENT | 0001104659-26-079319 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | OWNERSHIP DOCUMENT | 0001104659-26-079316 | View SEC Doc Filr Page |
| 6-K | 2026-06-26 | 2026-06-26 | FORM 6-K | 0001104659-26-077892 | View SEC Doc Filr Page |
| 424B5 | 2026-06-26 | — | 424B5 | 0001104659-26-077891 | View SEC Doc Filr Page |
| 6-K | 2026-06-25 | 2026-06-25 | FORM 6-K | 0001104659-26-077506 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-03 | — | SCHEDULE 13D/A Filing | 0001104659-26-070195 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-02 | OWNERSHIP DOCUMENT | 0001104659-26-070090 | View SEC Doc Filr Page |
| 6-K | 2026-06-02 | 2026-06-02 | FORM 6-K | 0001104659-26-069450 | View SEC Doc Filr Page |
| 3 | 2026-06-02 | 2026-06-02 | OWNERSHIP DOCUMENT | 0001104659-26-069449 | View SEC Doc Filr Page |